Skip to main content

Study M617

Study name

Huang XX 2020

Title

Serum metabonomic study on the antidepressant-like effects of ellagic acid in a chronic unpredictable mild stress-induced mouse model

Overall design

In this study, the effects and serum metabolomic analysis of ellagic acid against depression were investigated using a chronic unpredictable mild stress-induced (CUMS) model. C57BL/6 mice were divided into the following 3 groups (n = 12 in each group): (1) control group, (2) CUMS group, and (3) CUMS + ellagic acid group (stressor plus ellagic acid treatment at the dose of 100 mg/kg). The CUMS stress procedure lasted for 6 weeks, and drugs were administered via intragastric once per day during the model building period. Ellagic acid significantly ameliorated the CUMS-induced depression-like behaviors. Five serum samples per group were used for metabonomic analysis.

Study Type

Type1;

Type2;

Data available

Unavailable

Organism

Mouse; C57BL/6 mouse;

Categories of depression

Animal model; Chronic mild stress model; Chronic mild stress model;

Criteria for depression

Sucrose preference test, forced swimming test, tail suspension test

Sample size

15

Tissue

Peripheral; Blood; Serum;

Platform

MS-based; LC-MS: Agilent ACQUITY Ultraperformance Liquid Chromatography-quadrupole Time-of-flight Mass Spectrometry (UPLC-Q-TOF-MS, G6540B);

PMID

32786855

DOI

10.1021/acs.jafc.0c02895

Citation

Huang X, Li W, You B, et al. Serum metabonomic study on the antidepressant-like effects of ellagic acid in a chronic unpredictable mild stress-induced mouse model. J Agric Food Chem. 2020;68(35):9546-9556.

Metabolite

L-Arginine;

Uric acid;

L-Malic acid;

Orotic acid;

2-Hydroxyethanesulfonate;

N-Acetylserine;

4-Imidazolone-5-propionic acid;

Isoglutamine;

PE(22:1(13Z)/P-18:1(9Z));

PE(20:3(8Z,11Z,14Z)/20:0);

PE(20:3(8Z,11Z,14Z)/P-18:1(9Z));

PE(20:0/dm18:0);

PI(O-20:0/18:3(9Z,12Z,15Z));

PE(18:3(6Z,9Z,12Z)/20:0);

PE(20:3(5Z,8Z,11Z)/20:1(11Z);

PI(20:3(8Z,11Z,14Z)/18:2(9Z,12Z));

PI(20:3(8Z,11Z,14Z)/18:1(11Z));

PI(17:1(9Z)/19:1(9Z));

PI(17:0/17:2(9Z,12Z));

LysoPE(0:0/20:4(8Z,11Z,14Z,17Z));

N-stearoyl serine;

PE(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));

3-Deoxyarabinohexonic acid;

C17 Sphinganine;

MG(0:0/24:1(15Z)/0:0);